These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8416290)

  • 1. Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents.
    Ratnoff OD; Gleich GJ; Shurin SB; Kazura J; Everson B; Embury P
    Am J Hematol; 1993 Jan; 42(1):138-45. PubMed ID: 8416290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the activation of Hageman factor (factor XII) by human vascular endothelial cell culture supernates.
    Ratnoff OD; Everson B; Embury P; Ziats NP; Anderson JM; Emanuelson MM; Malemud CJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10740-3. PubMed ID: 1961740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII).
    Niwano H; Embury PB; Greenberg BD; Ratnoff OD
    J Lab Clin Med; 1995 Feb; 125(2):251-6. PubMed ID: 7844473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil granule proteins in peripheral blood granulocytes.
    Abu-Ghazaleh RI; Dunnette SL; Loegering DA; Checkel JL; Kita H; Thomas LL; Gleich GJ
    J Leukoc Biol; 1992 Dec; 52(6):611-8. PubMed ID: 1464733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent.
    Thorisdottir H; Ratnoff OD; Maniglia AJ
    J Lab Clin Med; 1988 Oct; 112(4):481-6. PubMed ID: 3171356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV, and V.
    Koenig JM; Chahine A; Ratnoff OD
    J Lab Clin Med; 1991 Jun; 117(6):523-7. PubMed ID: 1646270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil granule cationic proteins regulate the classical pathway of complement.
    Weiler JM; Edens RE; Bell CS; Gleich GJ
    Immunology; 1995 Feb; 84(2):213-9. PubMed ID: 7750997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil granule proteins activate human heart mast cells.
    Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
    J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
    Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
    J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of platelets by eosinophil granule proteins.
    Rohrbach MS; Wheatley CL; Slifman NR; Gleich GJ
    J Exp Med; 1990 Oct; 172(4):1271-4. PubMed ID: 2212954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol).
    Laurel MT; Ratnoff OD; Everson B
    J Lab Clin Med; 1992 May; 119(5):580-5. PubMed ID: 1374787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls in the quantitative estimation of the secretion of granule proteins by eosinophils.
    Bach MK; Brashler JR; Sanders ME; Bienkowski MJ
    J Immunol Methods; 1991 Sep; 142(2):243-50. PubMed ID: 1919027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.
    Ratnoff OD; Emanuelson MM; Ziats NP
    J Clin Invest; 1987 Oct; 80(4):1180-9. PubMed ID: 3498741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway.
    Weiler JM; Edens RE; Gleich GJ
    J Immunol; 1992 Jul; 149(2):643-8. PubMed ID: 1624807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of lodoxamide on eosinophil activation.
    Capron M; Loiseau S; Papin JP; Robertson S; Capron A
    Int Arch Allergy Immunol; 1998 Jun; 116(2):140-6. PubMed ID: 9652307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eosinophil-induced lung injury].
    Iwamoto I
    Kokyu To Junkan; 1991 Jun; 39(6):514-21. PubMed ID: 1871435
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments by popcorn inhibitor.
    Ratnoff OD; Moneme V
    Proc Soc Exp Biol Med; 1981 Feb; 166(2):297-9. PubMed ID: 7208489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.